The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Vastatins Inhibit Tissue Factor in Cultured Human Macrophages: A Novel Mechanism of Protection Against Atherothrombosis
Abstract
We examined the effect of fluvastatin, the first entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor that is structurally different from other vastatins, on tissue factor (TF) expression in human macrophages spontaneously differentiated in culture from blood monocytes. Fluvastatin decreased TF activity in a dose-dependent manner (1 to 5 μmol/L) in both unstimulated and lipopolysaccharide-stimulated macrophages, and this reduction paralleled the decrease in immunologically recognized TF protein. The same results were obtained with another lipophilic vastatin, simvastatin, but not with hydrophilic pravastatin. The reduction in TF expression was also observed in macrophages enriched in cholesterol after exposure to 50 μg/mL acetylated low density lipoprotein. The inhibitory effect of fluvastatin on TF activity and antigen was fully reversible by coincubation with 100 μmol/L mevalonate or 10 μmol/L all-trans-geranylgeraniol but not with dolichol, farnesol, or geraniol. Suppression of TF antigen and activity was accompanied by a diminution in TF mRNA levels, which was completely prevented by mevalonate. Furthermore, fluvastatin impaired bacterial lipopolysaccharide–induced binding of c-Rel/p65 heterodimers to a κB site in the TF promoter, indicating that this drug influences induction of the TF gene. We conclude that lipophilic vastatins inhibit TF expression in macrophages, and because this effect is prevented by mevalonate and geranylgeraniol, a geranylgeranylated protein plays a crucial role in the regulation of TF biosynthesis. The suppression of TF in macrophages by vastatins indicates a potential mechanism by which these drugs interfere with the formation and progression of atherosclerotic plaque as well as thrombotic events in hyperlipidemic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Basu, S. K., Goldstein, J. L., Anderson, G. W., & Brown, M. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3178 · Cited by 1,021
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 758
Tissue factor and hemostasis [published erratum appears in Blood 1988 Apr;71(4):1178]
Nemerson, Y. (1988) · Blood · doi:10.1182/blood.v71.1.1.1 · Cited by 682
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
The Structural Biology of Expression and Function of Tissue Factor
Edgington, T. S., Mackman, N., Brand, K., & Ruf, W. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646375 · Cited by 551
Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S. J., & Lespérance, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.959 · Cited by 499
Levi, M., ten Cate, H., Bauer, K. A., van der Poll, T., Edgington, T. S., Büller, H. R., van Deventer, S. J., Hack, C. E., ten Cate, J. W., & Rosenberg, R. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116934 · Cited by 406
Mackman, N., Brand, K., & Edgington, T. S. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1517 · Cited by 371
Nakanishi, M., Goldstein, J. L., & Brown, M. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68397-8 · Cited by 332
Human Lamin B Contains a Farnesylated Cysteine Residue
Farnsworth, C. C., Wolda, S. L., Gelb, M. H., & Glomset, J. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47079-8 · Cited by 323
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295
Regulation of the tissue factor gene
Mackman, N. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615158 · Cited by 269
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
Scandinavian Simvastation Survival Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90926-5 · Cited by 255
Soma, M. R., Donetti, E., Parolini, C., Mazzini, G., Ferrari, C., Fumagalli, R., & Paoletti, R. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.571 · Cited by 225
Self-citationCorsini, A., Mazzotti, M., Raiteri, M., Soma, M. R., Gabbiani, G., Fumagalli, R., & Paoletti, R. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90107-6 · Cited by 217
Self-citationThe ras superfamily of small GTP-binding proteins
Downward, J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90300-z · Cited by 175
Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal Volunteers
Tse, F. L. S., Jaffe, J. M., & Troendle, A. (1992) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1992.tb05773.x · Cited by 175
Prevention of restenosis by lovastatin after successful coronary angioplasty
Sahni, R., Maniet, A. R., Voci, G., & Banka, V. S. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90002-y · Cited by 161
Gellman, J., Ezekowitz, M. D., Sarembock, I. J., Azrin, M., Nochomowitz, L. E., Lerner, E., & Haudenschild, C. C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90735-r · Cited by 126
Oeth, P., Parry, G. C., KUNSCH, C. A., Nantermet, P. V., Rosen, C. A., & Mackman, N. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3772-3781.1994 · Cited by 121
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity
Cutts, J., Scallen, T. J., Watson, J. A., & Bankhurst, A. D. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390314 · Cited by 99
Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)
Hidaka, Y., Eda, T., Yonemoto, M., & Kamei, T. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90179-k · Cited by 95
Munro, E., Patel, M., CHAN, P., Betteridge, L. J., Clunn, G. F., Gallagher, K. L., Hughes, A. D., Schächter, M., Wolfe, J. H. N., & Sever, P. S. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01074.x · Cited by 87
Lesnik, P., Rouis, M., Skarlatos, S. I., Kruth, H. S., & Chapman, M. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10370 · Cited by 83
Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages
Bernini, F., Didoni, G., Bonfadini, G., Bellosta, S., & Fumagalli, R. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90172-q · Cited by 79
Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors
Sirtori, C. R. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90031-8 · Cited by 77
Tremoli, E., Camera, M., MADERNA, P., Sironi, L., Prati, L., Colli, S., Piovella, F., Bernini, F., Corsini, A., & Mussoni, L. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.338 · Cited by 71
Self-citationKreuzer, J., Bader, J., Jahn, L., Hautmann, M. B., Kübler, W., & Vonhodenberg, E. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90116-k · Cited by 66
Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages.
Kempen, H. J. M., Vermeer, M. A., de Wit, E., et al. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.146 · Cited by 63
Tremoli, E., Eligini, S., Colli, S., MADERNA, P., Risé, P., Pazzucconi, F., Marangoni, F., Sirtori, C. R., & Galli, C. L. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1600 · Cited by 57
Self-citationTerkeltaub, R. A., Solan, J. L., Barry, M. E., Santoro, D. A., & Bokoch, G. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.6.749 · Cited by 55
Procoagulant activity expression by macrophages from atheromatous vascular plaques
Tipping, P. G., Malliaros, J., & Holdsworth, S. R. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90129-9 · Cited by 52
Law, R. E., Stimmel, J. B., Damore, M. A., Carter, C., Clarke, S. G., & Wall, R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.103 · Cited by 52
Lipid modification of G proteins
Kinsella, B. T., & O’Mahony, D. J. (1994) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(94)90022-1 · Cited by 21
Blood lipids and human coronary atherosclerosis regression: the angiographic evidence
Blankenhorn, D. H. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199108000-00003 · Cited by 14
Cited by
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Statins: mechanism of action and effects
Stancu, C., & Sima, A. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00172.x · Cited by 911
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
Drug Treatment of Lipid Disorders
Knopp, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410707 · Cited by 845
Metadata
- Authors
- Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-02
- Volume
- 17
- Issue
- 2
- Pages
- 265-272
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2159633079
- Cited by
- 348
- References
- 46
- FWCI
- 22.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.